[1]
Ajayi, T. et al. 2018. Role of nucleoside/nucleotide analogues and low-dose hepatitis B immune globulin in prophylaxis of hepatitis B recurrence among cadaveric liver transplant recipients. Turkish Journal of Gastroenterology. 29, 1 (Jan. 2018), 61–66. DOI:https://doi.org/10.5152/tjg.2018.17595.